08037400111
English
Spanish
French
German
Italian
Chinese (Simplified)
Japanese
Korean
Arabic
Portuguese
Salbutamol Sulfate
8000 INR/Kilograms
Product Details:
- Melting Point 180
- Taste Other
- EINECS No 256-916-8
- Boiling point 433.5 at 760 mmHg
- HS Code 29051420
- Solubility Freely soluble in water, practically insoluble or very slightly soluble in ethanol (96 %) and in methylene chloride. It shows polymorphism
- Smell No Smell
- Supply Ability : 1000 Kilograms Per Day
- Click to view more
X
Price And Quantity
- 8000 INR/Kilograms
- 25 Kilograms
- 8000.00 - 9000.00 INR/Kilograms
Product Specifications
- C26H44N2O10S
- alpha.1-[(tert-Butylamino)methyl]-4-hydroxy-m-xylene-.alpha., .alpha.-diol sulfate (2:1) salt;Bronchospray;(+-)-Salbutamol sulfate;Albuterol sulfate (USP);1-(4-Hydroxy-3-hydroxymethylphenyl)-2-(tert-butylamino)ethanol sulfate;Loftan;Epaq;1,3-Benzenedimethanol, alpha1-(((1,1-dimethylethyl)amino)methyl)-4-hydroxy-, sulfate (2:1) (salt) (9CI);Ventolin HFA;Emican;Salbutamol hemisulfate;Broncho Inhalat;Huma-Salmol;Albuterol sulfate / Salbutamol sulfate;
- 1 Years
- Room Temperature
- 0.32 %
- 576.70 Grams (g)
- 576.70
- Salbutamol is a drug used in the treatment of asthma, a chronic lung disease caused by inflammation of the lower airways.
- white crystalline solid
- 3.510
- Medicine Grade
- 180
- Powder
- Pharmaceutical Intermediates
- 98%
- Other
- SALBUTAMOL SULPHATE
- 256-916-8
- 433.5 at 760 mmHg
- Freely soluble in water, practically insoluble or very slightly soluble in ethanol (96 %) and in methylene chloride. It shows polymorphism
- 29051420
- No Smell
- 51022-70-9
Trade Information
- Cash Advance (CA), Cash in Advance (CID), Cash Against Delivery (CAD), Letter of Credit (L/C), Telegraphic Transfer (T/T)
- 1000 Kilograms Per Day
- 7 Days
- Free samples are available
- DRUM
- Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa
- ISO, GMP
Product Description
Salbutamol Sulfate provided by us, is designed and manufactured by making use of premium grade of raw materials and upgraded technology. This sulfate obstructive pulmonary disease (COPD) such as coughing, wheezing and feeling breathless. This is clinically tested under various parameters to ensure its effectiveness and high performance. It is used to relieve symptoms of asthma and chronic diseases. This sulphate is very cost effective and can be easily purchased by our eminent customers, at nominal pricing, in bulk quantities.
Salbutamol Sulfate Properties:
- CAS Number: 51022-70-9
- Formula: 2(C13H21NO3).H2O4S
- Molecular Weight: 576.70
- Deleted CAS: 36519-31-0
- Synonyms: .alpha.1-[(tert-Butylamino)methyl]-4-hydroxy-m-xylene-.alpha., .alpha.-diol sulfate (2:1) salt;Bronchospray;(+-)-Salbutamol sulfate;Albuterol sulfate (USP); Ventolin HFA;Emican;Salbutamol hemisulfate;Broncho Inhalat;Huma-Salmol;Albuterol sulfate / Salbutamol sulfate; 1-(4-Hydroxy-3-hydroxymethylphenyl)-2-(tert-butylamino)ethanol sulfate;Loftan;Epaq;1,3-Benzenedimethanol, alpha1-(((1,1-dimethylethyl)amino)methyl)-4-hydroxy-, sulfate (2:1) (salt) (9CI);
- EINECS: 256-916-8
- Melting Point: 180 degree centigrade
- Boiling Point: 433.5 degree centigrade at 760 mmHg
- Flash Point: 159.5 degree centigrade
- Solubility: Soluble in water
- Appearance: White crystalline solid
How does it work
Asthma and chronic obstructive pulmonary disease (COPD) are treated with salbutamol to relieve symptoms in breathing, coughing, and wheezing. Breathing becomes easier when the muscles in the airways to the lungs are relaxed. The inhaler (puffer) contains salbutamol.
Applications Or where it is used
The medication is often prescribed for bronchospasm (resulting from allergic asthma or exercise-induced bronchospasm) and chronic obstructive pulmonary disease. The medicine is also widely used in rescue inhalers (short-term bronchodilators that relieve asthma attacks).
Manufacturing process
The process comprises following steps:
1. Chloromethylation reaction: Compound 1 is generated when p-hydroxy benzaldehyde and paraformaldehyde reacts under an acidic condition.
2. Hydrolysis reaction: Compound 1 undergoes hydrolysis under alkaline conditions to give compound.
How to use
You should inhale the prescribed medications into your lungs using a mouthpiece or mask as directed by your doctor, usually 3 or 4 times daily as needed. Treatments usually take between five and fifteen minutes each. Only use a nebulizer to administer this medication. The solution should not be swallowed or injected.
Dosage of usage
There are different doses for different patients. Take the medication exactly as directed by your doctor. Until your doctor instructs you otherwise, do not change your dose if it is different. Amount of medicine you take depends on how strong it is. You also have to take medicine according to the medical problem you are treating. This includes how many doses per day, how long you should wait between doses, and the length of time you should remain on the medicine.
Side effects
Below are few side effects:
- Headache
- Feeling nervous, restless, excitable and/or shaky
- Uneven heartbeat
- Bad taste
- Dry mouth
- Sore throat and cough
- Inability to sleep
Warnings and precautions while using Salbutamol Sulfate
You may notice that your wheezing or breathing will worsen because of paradoxical bronchospasm caused by this medicine. It could be fatal. When you or your child cough, have trouble breathing, shortness of breath, or wheeze after using this medicine, contact your doctor immediately.
Enter Buying Requirement Details
Other Products in 'Active Pharmaceuticals Ingredients (API)' category
Contact Us
- 311, Atlantis Heights, Sarabhai Main Road, Vadiwadi, Vadodara - 390007, Gujarat, India
- Phone :08037400111
- Fax :91-265-2313035
-
Send Inquiry
Mr. Nilesh Bansilal Sheth (Partner)
Mobile :08037400111
: nilesh.sheth70
MR. Tushar V. Kavade (Partner) : tushar.kavade
Send Inquiry
|
SHREEJI PHARMA INTERNATIONAL
All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.
Developed and Managed by Infocom Network Private Limited.
